Kenvue Inc.
Kenvue Inc. Announces Board Member Resignations and Appointments
Summary
On July 30, 2024, Kenvue Inc. announced the resignation of two board members, Peter M. Fasolo and Joseph J. Wolk, effective December 1, 2024. Simultaneously, the Board of Directors appointed two new members: Kathleen M. Pawlus, effective August 15, 2024, and Kirk L. Perry, effective immediately after the resignations on December 1, 2024. Ms. Pawlus will serve on the Audit Committee, and Mr. Perry will serve on the Compensation & Human Capital Committee.
Profitelligence Alerts
Get alerts for KVUE
Be first to know when Kenvue Inc. files with the SEC.
Filing Categories
Advertisement
About Kenvue Inc.
Kenvue Inc. is a consumer healthcare and pharmaceutical company. It focuses on delivering a range of health-centric products, spanning hygiene, pain relief, and other wellness categories. With deep-rooted expertise in pharmaceuticals, Kenvue Inc. targets the health and wellness needs of individuals, providing both prescription and over-the-counter solutions. The company has established itself as a vital entity in the consumer health sector, significantly impacting community health standards and individual lives. Positioned in the pharmaceutical industry, Kenvue Inc. collaborates with healthcare providers to enhance its product reach and efficacy. Its broad portfolio includes well-known brands and formulations that are trusted globally by consumers seeking reliable health solutions. As a player in this sector, Kenvue Inc. contributes to the enhancement of public health, highlighting its prominence in both domestic and international markets.
Official SEC Documents
Advertisement